F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Metabolic dysfunction-associated steatotic liver disease

Page 1 of 1 ( 23 items )
<<
1
>>

1	Metabolic dysfunction-associated steatotic liver disease: A story of muscle and mass 5/28/2025 7:32:57 AM \| Browse: 1 \| Download: 0
2	Association between weight fluctuation and the risk of metabolic dysfunction-associated steatotic liver disease 5/27/2025 7:04:47 AM \| Browse: 1 \| Download: 7
3	Open questions on how metabolic dysfunction-associated steatotic liver disease shapes the course of drug-induced liver injury 5/27/2025 7:04:45 AM \| Browse: 1 \| Download: 6
4	Bicuculline ameliorates metabolic dysfunction-associated steatotic liver disease by inhibiting the nuclear factor-kappa B pathway and reducing lipid accumulation 4/29/2025 9:13:41 AM \| Browse: 18 \| Download: 48
5	Metabolic dysfunction-associated steatotic liver disease and omega-6 polyunsaturated fatty acids: Friends or foes 3/26/2025 4:06:55 AM \| Browse: 11 \| Download: 39
6	Gut microbiota differences, metabolite changes, and disease intervention during metabolic - dysfunction - related fatty liver progression 3/26/2025 4:06:51 AM \| Browse: 11 \| Download: 36
7	Attenuation imaging: Diagnostic differences in hepatic steatosis for chronic hepatitis B vs metabolic dysfunction-associated steatotic liver disease patients 3/13/2025 10:11:05 AM \| Browse: 42 \| Download: 79
8	Mitochondrial mt12361A > G increased risk of metabolic dysfunction-associated steatotic liver disease among non-diabetes 2/26/2025 4:21:41 AM \| Browse: 16 \| Download: 106
9	Heart failure with preserved ejection fraction and metabolic dysfunction-associated steatotic liver disease: Twin challenges, one metabolic solution 2/25/2025 6:14:40 AM \| Browse: 30 \| Download: 65
10	Metabolic dysfunction-associated steatotic liver disease and type 2 diabetes: A dual threat to cardiac dysfunction progression 1/21/2025 6:56:33 AM \| Browse: 18 \| Download: 71
11	Inhibition of metabotropic glutamate receptor-5 alleviates hepatic steatosis by enhancing autophagy via activation of the AMPK signaling pathway 1/20/2025 7:38:46 AM \| Browse: 18 \| Download: 112
12	Fanlian Huazhuo Formula: A promising herbal preparation for metabolic liver disease 11/21/2024 7:04:50 AM \| Browse: 58 \| Download: 140
13	Interplay of gut microbiota, glucagon-like peptide receptor agonists, and nutrition: New frontiers in metabolic dysfunction-associated steatotic liver disease therapy 10/31/2024 10:42:49 AM \| Browse: 50 \| Download: 164
14	Statins decrease the risk of hepatocellular carcinoma in metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis 10/31/2024 7:40:52 AM \| Browse: 45 \| Download: 196
15	Metabolic dysfunction-associated steatotic liver disease-associated fibrosis and cardiac dysfunction in patients with type 2 diabetes 10/17/2024 2:38:59 PM \| Browse: 44 \| Download: 216
16	Hepatic angiotensin-converting enzyme 2 expression in metabolic dysfunction-associated steatotic liver disease and in patients with fatal COVID-19 8/13/2024 8:00:24 AM \| Browse: 56 \| Download: 226
17	Role of incretins and glucagon receptor agonists in metabolic dysfunction-associated steatotic liver disease: Opportunities and challenges 5/22/2024 11:33:24 AM \| Browse: 60 \| Download: 236
18	Gestational diabetes mellitus may predispose to metabolic dysfunction-associated steatotic liver disease 5/22/2024 11:33:24 AM \| Browse: 62 \| Download: 236
19	FibroScan-aspartate transaminase: A superior non-invasive model for diagnosing high-risk metabolic dysfunction-associated steatohepatitis 5/11/2024 10:58:28 AM \| Browse: 87 \| Download: 367
20	Metabolic dysfunction-associated steatotic liver disease: Navigating terminological evolution, diagnostic frontiers and therapeutic horizon-an editorial exploration 5/11/2024 10:58:27 AM \| Browse: 67 \| Download: 242
21	Disparate outcomes in Hispanic patients with metabolic dysfunction-associated steatotic liver disease/steatohepatitis and type 2 diabetes: Large cohort study 5/10/2024 11:51:40 AM \| Browse: 74 \| Download: 437
22	Omics-based biomarkers as useful tools in metabolic dysfunction-associated steatotic liver disease clinical practice: How far are we? 4/12/2024 4:45:44 PM \| Browse: 71 \| Download: 339
23	Recent advances in age-related metabolic dysfunction-associated steatotic liver disease 2/21/2024 9:11:33 AM \| Browse: 148 \| Download: 545

Page 1 of 1 ( 23 items )
<<
1
>>

1	Metabolic dysfunction-associated steatotic liver disease: A story of muscle and mass 5/28/2025 7:32:57 AM \| Browse: 1 \| Download: 0
2	Association between weight fluctuation and the risk of metabolic dysfunction-associated steatotic liver disease 5/27/2025 7:04:47 AM \| Browse: 1 \| Download: 7
3	Open questions on how metabolic dysfunction-associated steatotic liver disease shapes the course of drug-induced liver injury 5/27/2025 7:04:45 AM \| Browse: 1 \| Download: 6
4	Bicuculline ameliorates metabolic dysfunction-associated steatotic liver disease by inhibiting the nuclear factor-kappa B pathway and reducing lipid accumulation 4/29/2025 9:13:41 AM \| Browse: 18 \| Download: 48
5	Metabolic dysfunction-associated steatotic liver disease and omega-6 polyunsaturated fatty acids: Friends or foes 3/26/2025 4:06:55 AM \| Browse: 11 \| Download: 39
6	Gut microbiota differences, metabolite changes, and disease intervention during metabolic - dysfunction - related fatty liver progression 3/26/2025 4:06:51 AM \| Browse: 11 \| Download: 36
7	Attenuation imaging: Diagnostic differences in hepatic steatosis for chronic hepatitis B vs metabolic dysfunction-associated steatotic liver disease patients 3/13/2025 10:11:05 AM \| Browse: 42 \| Download: 79
8	Mitochondrial mt12361A > G increased risk of metabolic dysfunction-associated steatotic liver disease among non-diabetes 2/26/2025 4:21:41 AM \| Browse: 16 \| Download: 106
9	Heart failure with preserved ejection fraction and metabolic dysfunction-associated steatotic liver disease: Twin challenges, one metabolic solution 2/25/2025 6:14:40 AM \| Browse: 30 \| Download: 65
10	Metabolic dysfunction-associated steatotic liver disease and type 2 diabetes: A dual threat to cardiac dysfunction progression 1/21/2025 6:56:33 AM \| Browse: 18 \| Download: 71
11	Inhibition of metabotropic glutamate receptor-5 alleviates hepatic steatosis by enhancing autophagy via activation of the AMPK signaling pathway 1/20/2025 7:38:46 AM \| Browse: 18 \| Download: 112
12	Fanlian Huazhuo Formula: A promising herbal preparation for metabolic liver disease 11/21/2024 7:04:50 AM \| Browse: 58 \| Download: 140
13	Interplay of gut microbiota, glucagon-like peptide receptor agonists, and nutrition: New frontiers in metabolic dysfunction-associated steatotic liver disease therapy 10/31/2024 10:42:49 AM \| Browse: 50 \| Download: 164
14	Statins decrease the risk of hepatocellular carcinoma in metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis 10/31/2024 7:40:52 AM \| Browse: 45 \| Download: 196
15	Metabolic dysfunction-associated steatotic liver disease-associated fibrosis and cardiac dysfunction in patients with type 2 diabetes 10/17/2024 2:38:59 PM \| Browse: 44 \| Download: 216
16	Hepatic angiotensin-converting enzyme 2 expression in metabolic dysfunction-associated steatotic liver disease and in patients with fatal COVID-19 8/13/2024 8:00:24 AM \| Browse: 56 \| Download: 226
17	Role of incretins and glucagon receptor agonists in metabolic dysfunction-associated steatotic liver disease: Opportunities and challenges 5/22/2024 11:33:24 AM \| Browse: 60 \| Download: 236
18	Gestational diabetes mellitus may predispose to metabolic dysfunction-associated steatotic liver disease 5/22/2024 11:33:24 AM \| Browse: 62 \| Download: 236
19	FibroScan-aspartate transaminase: A superior non-invasive model for diagnosing high-risk metabolic dysfunction-associated steatohepatitis 5/11/2024 10:58:28 AM \| Browse: 87 \| Download: 367
20	Metabolic dysfunction-associated steatotic liver disease: Navigating terminological evolution, diagnostic frontiers and therapeutic horizon-an editorial exploration 5/11/2024 10:58:27 AM \| Browse: 67 \| Download: 242
21	Disparate outcomes in Hispanic patients with metabolic dysfunction-associated steatotic liver disease/steatohepatitis and type 2 diabetes: Large cohort study 5/10/2024 11:51:40 AM \| Browse: 74 \| Download: 437
22	Omics-based biomarkers as useful tools in metabolic dysfunction-associated steatotic liver disease clinical practice: How far are we? 4/12/2024 4:45:44 PM \| Browse: 71 \| Download: 339
23	Recent advances in age-related metabolic dysfunction-associated steatotic liver disease 2/21/2024 9:11:33 AM \| Browse: 148 \| Download: 545